Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Authors

Showing 4 results for author "Faiza Khalid".

Back to authors

Thumbnail for The Pareto Optimization of Cure: A Primary Bivariate Copula Meta-Analysis Solving the Graft-Versus-Leukemia Paradox in Acute Myeloid Leukemia

AML - 1601

The Pareto Optimization of Cure: A Primary Bivariate Copula Meta-Analysis Solving the Graft-Versus-Leukemia Paradox in Acute Myeloid Leukemia

Faiza Khalid

Poster Presenter: Faiza Khalid

Thumbnail for Attention Is All You Need for De-Escalation: A Time-Series Transformer Meta-Analysis of Dynamic PET Kinetics and Toxicity in Hodgkin Lymphoma

HL - 1613

Attention Is All You Need for De-Escalation: A Time-Series Transformer Meta-Analysis of Dynamic PET Kinetics and Toxicity in Hodgkin Lymphoma

Faiza Khalid

Poster Presenter: Faiza Khalid

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Serum Ferritin as a Continuous Risk Factor for MACE and Leukemic Transformation in Myelodysplastic Neoplasms: A Restricted Cubic Spline Dose-Response Meta-Analysis and a Methodological Proof-of-Concept Study

MDS - 1556

Serum Ferritin as a Continuous Risk Factor for MACE and Leukemic Transformation in Myelodysplastic Neoplasms: A Restricted Cubic Spline Dose-Response Meta-Analysis and a Methodological Proof-of-Concept Study

Faiza Khalid

Poster Presenter: Faiza Khalid

$Thumbnail for Gastrointestinal Toxicities and Hepatotoxicity Profiles of Emerging CELMoDs Versus Next-Generation Proteasome Inhibitors in Relapsed/Refractory Multiple Myeloma: A Systematic Review With Pooled Proportion Analysis$

MM - 1441

Gastrointestinal Toxicities and Hepatotoxicity Profiles of Emerging CELMoDs Versus Next-Generation Proteasome Inhibitors in Relapsed/Refractory Multiple Myeloma: A Systematic Review With Pooled Proportion Analysis

Faiza Khalid

Poster Presenter: Faiza Khalid

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors